Haploinsufficiency of TNXB Is Associated with Hypermobility Type of Ehlers-Danlos Syndrome
Open accessThe DOI matches its Crossref record; 14 of the 16 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, there have also been reports of heterozygous TNXB gene mutations causing tenascin-X haploinsufficiency, which also results in the signs and symptoms of hypermobile-type EDS [14, 19, 20].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Family members with a haploinsufficient mutation in the TNXB gene have been described to have symptoms of joint hypermobility in 60% of the cases, but more research is needed to confirm this [Zweers et al., 2003].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zweers et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase de fi ciency have CAH-X syndrome, a connective tissue dysplasia consistent with hypermobility-type Ehlers-Danlos syndrome due to a contiguous gene deletion involving the adjacent CYP21A2 and TNXB genes.”
From High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. (2019) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The serum tenascin-X test based on enzyme-linked immunosorbent assay has been used to identify complete de fi ciency, but it is not accurate in identifying heterozygous forms and is not commercially available for general practice. 9,10”
From High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. (2019) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The authors concluded that TNXB haploinsufficiency is associated with hEDS [Zweers et al., 2003].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zweers et al., 2003
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Articular mobility in an African population.
Beighton, P., Solomon, L., & Soskolne, C. L. (1973) · Annals of the Rheumatic Diseases · doi:10.1136/ard.32.5.413 · Cited by 1,727
Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects
(2002) · Wiley eBooks · doi:10.1002/0471221929 · Cited by 949
(2000) · PubMed · Cited by 738
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
Self-citationTenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366
Self-citationSteinmann, B., Royce, P. M., & Superti‐Furga, A. (2002) · Connective Tissue and Its Heritable Disorders · doi:10.1002/0471221929.ch9 · Cited by 358
Joint hypermobility and genetic collagen disorders: are they related?
Grahame, R. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.80.2.188 · Cited by 344
Mao, J. R., Taylor, G., Dean, W. B., Wagner, D. R., Afzal, V., Lotz, J. C., Rubin, E. M., & Bristow, J. (2002) · Nature Genetics · doi:10.1038/ng850 · Cited by 261
Self-citationHypermobility: features and differential incidence between the sexes
Larsson, L., Baum, J., & Mudholkar, G. S. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301216 · Cited by 245
Byers, P. H. (1994) · Journal of Investigative Dermatology · doi:10.1038/jid.1994.9 · Cited by 133
Cited by
Items 101–200 of 243
Scicluna, K., Formosa, M. M., Farrugia, R., & Borg, I. (2022) · Clinical Genetics · doi:10.1111/cge.14026 · Cited by 20
“This study, despite having comparable results, is distinguished from those conducted by Zweers et al.2,40,41 as subjects were assessed using the 2017 diagnostic criteria and analysed using HTS.”
BackgroundInfluentialResequencing of candidate genes for Keratoconus reveals a role for Ehlers–Danlos Syndrome genes
Fransén, E., Valgaeren, H., Janssens, K., Sommen, M., Ridder, R. D., Vandeweyer, G., Bisceglia, L., Soler, V. J., Hoischen, A., Mortier, G. R., et al. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00849-2 · Cited by 22
Biomarkers for Ehlers-Danlos Syndromes: There Is a Role?
Caliogna, L., Guerrieri, V., Annunziata, S., Bina, V., Brancato, A. M., Castelli, A., Jannelli, E., Ivone, A., Grassi, F. A., Mosconi, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810149 · Cited by 24
“While truncating mutations and deletions in tnxb, resulting in Tenascin X deficiency [56,57], were found in patients with major and minor diagnostic criteria for cEDS type [56], tnxb haploinsufficiency has been found in patients with an autosomal dominant form of hEDS who did not show easy bruising and skin hyperexten…”
BackgroundBánlaki, Z., Doleschall, M., Rajczy, K., Füst, G., & Szilágyi, Á. (2012) · Genes and Immunity · doi:10.1038/gene.2012.29 · Cited by 22
Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome
Yassin, O., & Rihani, F. B. (2006) · Journal of Clinical Pediatric Dentistry · doi:10.17796/jcpd.30.4.72426m58695tg2h0 · Cited by 27
Morissette, R., Merke, D. P., & McDonnell, N. B. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2013.12.004 · Cited by 21
Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome
Marino, R. M., Moresco, A., Garrido, N. P., Ramírez, P., & Belgorosky, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.803226 · Cited by 23
Zweers, M. C., Peeters, A. C. T. M., Graafsma, S. J., Kranendonk, S. E., van der Vliet, J. A., den Heijer, M., & Schalkwijk, J. (2006) · Circulation · doi:10.1161/circulationaha.104.513820 · Cited by 23
Self-citationKraft, T. A., Grützmann, K., Meinhardt, M., Meier, F. E., Westphal, D., & Seifert, M. (2023) · Scientific Reports · doi:10.1038/s41598-022-24940-w · Cited by 36
Ali, A. A., Andrzejowski, P., Kanakaris, N. K., & Giannoudis, P. V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123992 · Cited by 25
“Haploinsufficiency and missense variants of tenascin-X, which is an extracellular matrix protein encoded by the TNXB gene, has been reported in a handful of hEDS phenotype individuals [51,52].”
BackgroundNo improvement in a pilot study of tai chi exercise in rheumatoid arthritis
Uhlig, T., Larsson, C., Hjorth, A.-G., Ødegård, S., & Kvien, T. K. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.022483 · Cited by 18
Multiple venous thrombosis in SAPHO syndrome
Kawabata, T., Morita, Y., Nakatsuka, A., Kagawa, H., Kawashima, M., Sei, T., Yamamura, M., & Makino, H. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.027722 · Cited by 18
Mackenroth, L., Fischer‐Zirnsak, B., Egerer, J., Hecht, J., Kallinich, T., Stenzel, W., Spors, B., von Moers, A., Mundlos, S., Kornak, U., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37547 · Cited by 18
“Most of the biallelic mutations in TNXB known to cause hypermobility EDS phenotype are truncating mutations (i.e., deletions, stop, or frameshift mutations) [Zweers et al., 2003].”
BackgroundCastori, M. (2013) · PubMed · Cited by 24
Tenascin-X Induces Cell Detachment through p38 Mitogen-Activated Protein Kinase Activation
Fujie, S., Maita, H., Ariga, H., & Matsumoto, K. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1795 · Cited by 21
Disorders of Connective Tissue
Burrows, N., & Lovell, C. R. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch45 · Cited by 29
Joint Hypermobility Syndrome in Patients With Functional Dyspepsia
Carbone, F., Fikree, A., Aziz, Q., & Tack, J. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000220 · Cited by 16
Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy
Miller, W. L., Pandey, A. V., & Flück, C. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae815 · Cited by 17
A method for quantification of serum tenascin-X by nano-LC/MS/MS
Yamada, K., Watanabe, A., Takeshita, H., & Matsumoto, K. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.022 · Cited by 17
Lao, Q., Mallappa, A., Faucz, F. R., Joyal, E., Veeraraghavan, P., Chen, W., & Merke, D. P. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1556 · Cited by 17
“However, a subset of subjects with hypermobility EDS have been identified to have defects in TNXB, which encodes tenascin-X (TNX), a large glycoprotein essential for the constitution of the extracellular matrix (ECM) (Burch et al., 1997; Merke et al., 2013; Morissette et al., 2015; Schalkwijk et al., 2001; Zweers et a…”
BackgroundIdentification and characterization of multiple species of tenascin‐X in human serum
Egging, D. F., Peeters, A. C. T. M., Grebenchtchikov, N. I., Geurts-Moespot, A. J., Sweep, F. C. G. J., den Heijer, M., & Schalkwijk, J. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05671.x · Cited by 18
Self-citationWatanabe, A., Satoh, K., Maniwa, T., & Matsumoto, K. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2437 · Cited by 17
“%) of the individuals presented with generalized joint hypermobility, recurring joint dislocations and chronic joint pain, as seen in patients with JHS/EDS-HT, whereas 6 (7.5”
InfluentialUnderstanding the basis of Ehlers–Danlos syndrome in the era of the next-generation sequencing
Cortini, F., Villa, C., Marinelli, B., Combi, R., Pesatori, A. C., & Bassotti, A. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01894-0 · Cited by 16
Wang, J., Liu, C., Chen, J., Bai, Y., Wang, K., Wang, Y., & Fang, M. (2020) · Genes · doi:10.3390/genes11030275 · Cited by 18
“For example, REG3G, IER3, SGMS2, and DKK2 [52–55] are involved in skeletal development, TNXB [56] in muscle growth, CH25H, DRG1 [57,58] in digestive secretion, and NGLY [59] in vision.”
BackgroundThe Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
CAH-X Syndrome: Genetic and Clinical Profile
Concolino, P., & Falhammar, H. (2022) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-022-00588-0 · Cited by 19
“While TNX deficiency causes a clinically distinct, severe form of Ehlers Danlos syndrome (EDS) with a pattern of autosomal recessive inheritance, heterozygous TNXB pathogenic variants cause TNX haploinsufficiency related to hypermobility-type EDS [17, 18].”
BackgroundRare variants in tenascin genes in a cohort of children with primary vesicoureteric reflux
Elahi, S., Homstad, A., Vaidya, H., Stout, J., Hall, G., Wu, G., Conlon, P. J., Routh, J. C., Wiener, J. S., Ross, S. S., et al. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3203-6 · Cited by 14
TNX deficiency results in bone loss due to an increase in multinucleated osteoclasts
Kajitani, N., Yamada, T., Kawakami, K., & Matsumoto, K. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.134 · Cited by 16
Mosca‐Boidron, A., Callier, P., Masurel, A., Thauvin‐Robinet, C., Marle, N., Nouchy, M., Huet, F., Dipanda, D., Paepe, A. D., Coucke, P. J., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33254 · Cited by 14
Broussais, F., Kawashima, M., Marotte, H., & Miossec, P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.021378 · Cited by 14
Paragliola, R. M., Perrucci, A., Foca, L., Urbani, A., & Concolino, P. (2022) · doi:10.20944/preprints202206.0329.v1 · Cited by 13
Paragliola, R. M., Perrucci, A., Foca, L., Urbani, A., & Concolino, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133818 · Cited by 17
A Family-Based Study of Inherited Genetic Risk in Lipedema
Morgan, S., Reid, I., Bendon, C. L., Ishaq, M., Shayan, R., Pope, B. J., Park, D. J., & Karnezis, T. (2024) · Lymphatic Research and Biology · doi:10.1089/lrb.2023.0065 · Cited by 25
Compound heterozygosity for TNXB genetic variants in a mixed‐breed dog with Ehlers‐Danlos syndrome
Bauer, A., Lucia, M. D., Leuthard, F., Jagannathan, V., & Leeb, T. (2019) · Animal Genetics · doi:10.1111/age.12830 · Cited by 15
Concolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
“The functional consequence of this rearrangement is the complete absence of the 21OH enzyme and the deficiency of tenascin-X [48, 62], while the resulting phenotype is a hypermobility form of Ehlers-Danlos syndrome (EDS).”
Doolan, B. J., Lavallee, M. E., Haußer, I., Pope, F. M., Seneviratne, S. L., Winship, I., & Burrows, N. (2023) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.01.034 · Cited by 13
Matricellular proteins in immunometabolism and tissue homeostasis
Eun, K., Kim, A. Y., & Ryu, S. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0156 · Cited by 13
The Ehlers–Danlos Syndromes against the Backdrop of Inborn Errors of Metabolism
Damme, T. V., Colman, M., Syx, D., & Malfait, F. (2022) · Genes · doi:10.3390/genes13020265 · Cited by 17
“Additionally, in a subset of individuals presenting generalized joint hypermobility, heterozygous TNXB variants were identified that lead to TNXB haploinsufficiency [60].”
BackgroundA potential contribution of tenascin-X to blood vessel formation in peripheral nerves
Sakai, H., Yokota, S., Kajitani, N., Yoneyama, T., Kawakami, K., Yasui, Y., & Matsumoto, K. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.06.003 · Cited by 16
“Complete TNX deficiency and TNX haploinsufficiency are associated with a classical type of EDS and a hypermobility type of EDS (Burch et al., 1997; Schalkwijk et al., 2001; Zweers et al., 2003; Zweers et al., 2004).”
InfluentialGenetic complexity of diagnostically unresolved Ehlers-Danlos syndrome
Vandersteen, A. M., Weerakkody, R. A., Parry, D. A., Kanonidou, C., Toddie-Moore, D., Vandrovcová, J., Darlay, R., Santoyo‐López, J., Meynert, A. M., BioResource, N., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2023-109329 · Cited by 15
Bohora, S. (2010) · PubMed Central · Cited by 17
Hypermobility syndromes from the clinician's perspective: an overview.
Jacobs, J. W. G., & da Silva, J. A. P. (2014) · PubMed · Cited by 16
Hamel, B. C. J. (2004) · PubMed · Cited by 11
Self-citationBurrows, N. (2019) · Wiley eBooks · doi:10.1002/9781119142812.ch93 · Cited by 11
Macronodular adrenocortical hyperplasia in a postmenopausal woman.
Mijnhout, G. S., Danner, S. A., van de Goot, F. R. W., & van Dam, E. W. C. M. (2004) · PubMed · Cited by 10
Suppression of hepatic dysfunction in tenascin-X-deficient mice fed a high-fat diet
YAMAGUCHI, S., Kawakami, K., Satoh, K., Fukunaga, N., Akama, K., & Matsumoto, K. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7052 · Cited by 11
“Conversely, TNX haploinsufficiency is associated with the hypermobility type of EDS (13).”
InfluentialLamari, N. M., & Beighton, P. (2023) · In clinical practice · doi:10.1007/978-3-031-34914-0_7 · Cited by 10
Ehlers–Danlos syndrome: A cause of epilepsy and periventricular heterotopia
Verrotti, A., Monacelli, D., Castagnino, M., Villa, M. P., & Parisi, P. (2014) · Seizure · doi:10.1016/j.seizure.2014.07.014 · Cited by 9
Pournasiri, Z., Madani, A., Zandi, H., Salehpour, S., Gorji, F. A., & Ahmadzahe, A. (2014) · Iranian Journal of Kidney Diseases · Cited by 12
Germain, D. P. (2017) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2017.06.017 · Cited by 9
Kolli, V., Kim, H., Rao, H., Lao, Q., Gaynor, A., Milner, J. D., & Merke, D. P. (2019) · BMC Research Notes · doi:10.1186/s13104-019-4753-7 · Cited by 9
Brisset, M., Métay, C., Carlier, R., Badosa, C., Marques, C., Schalkwijk, J., vanVlijmen-Willems, I., Jimenez-Mallebrera, C., Keren, B., Jobic, V., et al. (2020) · Neuromuscular Disorders · doi:10.1016/j.nmd.2020.09.002 · Cited by 13
Self-citationShimada, S., Yoshizawa, T., Takahashi, Y., Nitahara‐Kasahara, Y., Okada, T., Nomura, Y., Yamanaka, H., Kosho, T., & MATSUMOTO, K. (2020) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.19-0150 · Cited by 9
Foy, M., de Mazancourt, P., Métay, C., Carlier, R., Allamand, V., Gartioux, C., Gillas, F., Miri, N., Jobic, V., Mekki, A., et al. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4128 · Cited by 7
Anetodermic pilomatricoma in a patient with hypermobility syndrome
Chattopadhyay, M., Rytina, E., Sterling, J. C., & Burrows, N. P. (2013) · Clinical and Experimental Dermatology · doi:10.1111/ced.12215 · Cited by 7
Measurement of Serum Tenascin-X in Joint Hypermobility Syndrome Patients
Yamada, K., Watanabe, A., Takeshita, H., Fujita, A., Miyake, N., Matsumoto, N., & Matsumoto, K. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00168 · Cited by 7
Joint Hypermobility Syndrome and Membrane Proteins: A Comprehensive Review
Pliego-Arreaga, R., Cervantes‐Montelongo, J. A., Silva-Martínez, G. A., Tristán-Flores, F. E., Pantoja-Hernández, M. Á., & Maldonado-Coronado, J. R. (2024) · Biomolecules · doi:10.3390/biom14040472 · Cited by 9
“There are some outstanding reports that provide important information for a better understanding of hEDS at a proteomic level with potential extrapolation to be used as a serum biomarker (Table 1) [4,7,37,39,47–50].”
BackgroundInfluentialPrimary Disorders of Connective Tissue
Cole, W. G., & Mäkitie, O. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00054-5 · Cited by 7
Ajayi, O. O., Adefenwa, M. A., Agaviezor, B. O., Ikeobi, C. O. N., Wheto, M., Okpeku, M., Amusan, S. A., Yakubu, A., Donato, M. D., PETERS, S. O., et al. (2013) · Biochemical Genetics · doi:10.1007/s10528-013-9622-9 · Cited by 6
“Although tenascin-X protein is abundantly expressed in almost all the connective tissues (Zweers et al. 2003), it is not expressed in lymphoid organs.”
BackgroundByers, P. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00161-0 · Cited by 7
Isley, L. J., Callum, P., Luque, J., Park, J., & Baldwin, K. (2023) · F&S Reports · doi:10.1016/j.xfre.2023.10.005 · Cited by 5
Genetic diagnosis of the Ehlers-Danlos syndromes
Zschocke, J., Demirdas, S., & van Dijk, F. S. (2024) · Medizinische Genetik · doi:10.1515/medgen-2024-2061 · Cited by 9
Garcı́a-Castro, M., Martinez-Merino, T., Puente, N., & Riancho, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010036 · Cited by 5
“A recessive mode of inheritance was reported, although some heterozygous relatives showed mild manifestations [7,8].”
BackgroundHermanns‐Lê, T., Pierard, G., Piérard-Franchimont, C., & Delvenne, P. (2014) · Gynecology · doi:10.7243/2052-6210-2-1 · Cited by 6
“Sporadic mutations, such as TNXB haploinsufficiency, were reported in hypermobile EDS, although mutations remain undisclosed in the majority of cases [8].”
BackgroundThe Differential Diagnosis of Adult Osteogenesis Imperfecta
Burshell, A., & Pasala, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397165-4.00028-9 · Cited by 5
Byers, P. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05626-9 · Cited by 5
Burrows, N., Sidhu‐Malik, N., & Yeowell, H. N. (2011) · Wiley eBooks · doi:10.1002/9781444345384.ch142 · Cited by 5
Genetics of the Ehlers–Danlos syndrome: More than collagen disorders
Van Damme, T., Syx, D., Coucke, P., Symoens, S., De Paepe, A., & Malfait, F. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1022528 · Cited by 4
“Subsequently, reduced TNX serum levels were found in ~ 5 -- 10% of patients diagnosed with the hypermobility subtype of EDS [114].”
BackgroundFanis, P., Skordis, N., Phylactou, L. A., & Neocleous, V. (2023) · HORMONES · doi:10.1007/s42000-022-00410-w · Cited by 4
“The father of the neonate who was a carrier of the chimeric TNXA/TNXB (CAH-X CH-1) genotype also did not present any clinical manifestations of EDS.”
BackgroundInfluentialLiang, L., Wu, H., Meng, H., Fu, L., & Zhao, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1322395 · Cited by 4
Congenital Adrenal Hyperplasia, Ovarian Failure and Ehlers-Danlos Syndrome due to a 6p Deletion
Moysés‐Oliveira, M., Mancini, T. I., Takeno, S. S., Rodrigues, A. D. S., Bachega, T. A. S. S., Bertola, D. R., & Melaragno, M. I. (2014) · Sexual Development · doi:10.1159/000363779 · Cited by 4
Falcini, F., Giani, T., Lippi, A., Resti, M., & Simonini, G. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.026971 · Cited by 3
The role of TNXB single‐nucleotide polymorphisms in recurrent shoulder dislocation
Geiger, E. V., Henrich, D. M., Wutzler, S., Schneidmüller, D., Jakob, H., Frank, J. M., & Marzi, İ. (2012) · Journal of Orthopaedic Research® · doi:10.1002/jor.22231 · Cited by 4
“Unlike classic EDS patients, the phenotype of those patients reported by Zweers et al.(6) lack atrophic scars, suggesting various molecular associations.”
BackgroundResultInfluentialSkin Ultrastructural Clues on the Impact of Ehlers-Danlos Syndrome in Women
Hermanns‐Lê, T. (2016) · Journal of Dermatological Research · doi:10.17554/j.issn.2413-8223.2016.01.9 · Cited by 4
Ehlers-Danlos Syndrome: A Multidisciplinary Approach
Jacobs, J. W. G., Cornelissens, L. J. M., Veenhuizen, M. C., & Hamel, B. C. J. (2018) · IOS Press eBooks · doi:10.3233/978-1-61499-878-5-i · Cited by 10
Self-citationClinical and Ultrastructural Skin Alterations in the Ehlers-Danlos Syndrome, Hypermobility Type
Hermanns‐Lê, T., Pierard, G., Manicourt, D. H., & Piérard-Franchimont, C. (2016) · Dermatology - Open Journal · doi:10.17140/drmtoj-1-107 · Cited by 3
Diagnosing Monogenic Stroke at Younger Age
Ilinca, A., Kafantari, E., Wallenius, J., Kristoffersson, U., Englund, E. M., Puschmann, A., & Lindgren, A. G. (2024) · Stroke · doi:10.1161/strokeaha.124.048044 · Cited by 3
Angeborene Bindegewebserkrankungen mit skelettalem Phänotyp
Brenner, R. E., & Taurman, R. (2017) · Orthopädie und Unfallchirurgie up2date · doi:10.1055/s-0042-109019 · Cited by 3
“Bei einem geringen Prozentsatz der Patienten mit Hypermobilitäts-Typ des EDS wurden heterozygote Mutationen des Tenascin-X nachgewiesen [60].”
BackgroundChen, H. (2017) · Springer eBooks · doi:10.1007/978-1-4939-2401-1_78 · Cited by 3
Heritable Hypermobility Syndromes
Beighton, P., Grahame, R., & Bird, H. A. (2011) · Springer eBooks · doi:10.1007/978-1-84882-085-2_9 · Cited by 3
Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X
Lao, Q., Zhou, K., Parker, M., Faucz, F. R., & Merke, D. P. (2023) · Genes · doi:10.3390/genes14020265 · Cited by 1
“Concomitant hEDS in CAH has been associated with TNXB, which encodes tenascin-X, a glycoprotein crucial in ECM composition [5,6,26].”
BackgroundRadler, C. N., Wang, T., LeGate, J. F., Crone, L., Deo, P., Wortley, J., Moore, P., Bryant, G., Smitherman, K., & Sathyamoorthy, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136535 · Cited by 2
“A heterozygous loss of function causing TNXB haploinsufficiency leads to a milder hypermobility form of cEDS that lacks skin features and was first observed in family members of individuals with cEDS [14].”
Smieszek, S. P., Carlin, J. L., Fisher, M. A., Madonick, D., Kupersmith, C., Moszczynski, P., Xiao, C., Polymeropoulos, C. M., Birznieks, G., & Polymeropoulos, M. H. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000521 · Cited by 2
“Haploinsufficiency of TNXB was previously described in association with EDS subtypes (19).”
BackgroundShirvani, P., Shirvani, A., & Holick, M. F. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020134 · Cited by 7
“Heterozygous mutations affecting collagen organization and ECM integrity [72].”
Classification, nosology and diagnostics of Ehlers-Danlos syndrome
Hamel, B. C. J. (2019) · Journal of Biomedicine and Translational Research · doi:10.14710/jbtr.v5i2.4531 · Cited by 4
“heterozygosity for a pathogenic TNX-B mutation, is found both in cases with EDS hypermobility type and cases in whom BJHS is the more likely diagnosis.(25) Also, a changing phenotype from one diagnosis into the other in one individual and in some pedigrees the occurrence of both diagnoses argued for this statement.”
BackgroundSelf-citationMolecular Diagnosis of Genodermatoses
Wessagowit, V. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-227-8_3 · Cited by 3
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
Clinical and genetic parallels of the classification and diagnosis of Ehlers-Danlos syndrome
Nadyrshina, D. D., Тюрин, А. В., Хуснутдинова, Э. К., & Хусаинова, Р. И. (2021) · Nauchno-prakticheskii zhurnal «Medicinskaia genetika» · doi:10.25557/2073-7998.2021.06.14-26 · Cited by 2
Carvalho, H. C., Machado, N. C. S. S., Yáñez‐Silva, A., Rocabado, M., Júnior, A. R. D. P., Alves, L. P., Ribeiro, W., & Lazo-Osório, R. A. (2022) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2022.103903 · Cited by 3
Celli, M., Iacovino, C., Febbo, A., Lotti, L. V., Miraglia, E., Celli, L., Roberti, V., Sernicola, A., Zambrano, A., Turchetti, A., et al. (2020) · La Clinica Terapeutica · doi:10.7417/ct.2020.2253 · Cited by 5
Monlong, J., Chen, X., Barseghyan, H., Rowell, W. J., Negi, S., Nokoff, N., Mohnach, L. H., Hirsch, J. A., Finlayson, C. A., Keegan, C. E., et al. (2025) · medRxiv · doi:10.1101/2025.02.07.25321404 · Cited by 3
Die Ehlers-Danlos-Syndrome mit Schwerpunkt auf dem hypermobilen Typ: Literaturreview und Update
Sturm, K., & Bohn, M. (2019) · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen · doi:10.1007/s41970-019-0058-5 · Cited by 1
Embryological Development of the Lower Urinary Tract and the Genes Involved
Darlow, J. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-95091-9_5 · Cited by 1
Syndrome d'hypermobilité articulaire bénigne
Quintrec, J.-S. G.-L., & Legoupil, N. (2010) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(10)50997-5 · Cited by 1
Skeith, L., Jackson, S. C., BROOKS, J., & Poon, M. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2010.02214.x · Cited by 1
Giampietro, P. F. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1406-4_7 · Cited by 1
Junkiert-Czarnecka, A., Pilarska-Deltow, M., Bąk, A., Heise, M., & Haus, O. (2023) · Advances in Dermatology and Allergology · doi:10.5114/ada.2022.124107 · Cited by 1
“Some reports point to the TNXB gene as an hEDS genetic factor [3, 4].”
BackgroundThe Molecular Basis of Joint Hypermobility
Beighton, P., Grahame, R., & Bird, H. A. (2011) · Springer eBooks · doi:10.1007/978-1-84882-085-2_3 · Cited by 1
Search for molecular markers of joint hypermobility
Akhiiarova, K. E., Khusainova, R. I., Yalaev, B. I., & Tyurin, A. V. (2024) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2024-10-2-0-2 · Cited by 1
Delayed Wound Healing in a Young Patient with TNXB Variants and the Role of WES
Holmes, K., Shah, P., Jones, M. L., Langston, R., Asumda, F. Z., & Yu, J. C.-K. (2024) · FACE · doi:10.1177/27325016241274964 · Cited by 1
Metadata
- Authors
- Zweers, M. C., Bristow, J., Steijlen, P. M., Dean, W. B., Hamel, B. C., Otero, M., Kucharekova, M., Boezeman, J. B., & Schalkwijk, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Zweers, Manon C.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 73
- Issue
- 1
- Pages
- 214-217
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1180584
- OpenAlex
- W2034854893
- Cited by
- 242
- References
- 16
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 14 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 14 · 2019: 13 · 2018: 6 · 2017: 9 · 2016: 11 · 2015: 13 · 2014: 11 · 2013: 15 · 2012: 15
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3671 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (5r01hl060875-03)
- National Heart, Lung, and Blood Institute (HL-60875)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Keywords
- benign joint hypermobility syndrome, TNXB, haploinsufficiency, type XI collagen, COL11A1, COL11A2, COL3A1, connective tissue diseases, missense mutations, genotype-phenotype correlation
- MeSH terms
- Adult, Ehlers-Danlos Syndrome, Female, Haplotypes, Humans, Male, Middle Aged, Pedigree, Tenascin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.